Marc Duey

APRE

Marc Duey serves as Director at Aprea Therapeutics, Inc. (APRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$157.2K

Total Sells

1 trades

$29.6K

Net Position

Net Buyer

$127.6K

Companies Traded

APRE

Active Period

Oct 2024 – Dec 2025

4 total trades

Most Recent

Buy APRE

Dec 10, 2025 · $25.0K

Marc Duey's Insider Trading at Aprea Therapeutics, Inc. (APRE)

Buys

3 · $157.2K

Sells

1 · $29.6K

Total Shares Bought

51,649

Total Shares Sold

6,462

APRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 10, 2025↗	Buy	21,459	$1.16	$25.0K
Oct 18, 2024↗	Sell	6,462	$4.58	$29.6K
Oct 16, 2024↗	Buy	30,000	$4.39	$131.7K
Oct 14, 2024↗	Buy	190	$2.58	$490.20

Related Insiders

Oren Gilad

President/CEO

APREBuy · Jan 30, 2026

John P. Hamill

officer: SrVP/CFO/Prin Fin & Acct Ofcr

APREBuy · Jan 30, 2026

John P. Hamill

SrVP/CFO/Prin Fin & Acct Ofcr

APREBuy · Jan 30, 2026

Explore More Insider Trading Data

APRE Insider Trading Activity

View all insider trades at Aprea Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity